Patents by Inventor Noah Craft

Noah Craft has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEM AND METHOD FOR PROBLEM-ORIENTED PATIENT-CONTEXTUALIZED MEDICAL SEARCH AND CLINICAL DECISION SUPPORT TO IMPROVE DIAGNOSTIC, MANAGEMENT, AND THERAPEUTIC DECISIONS
    Publication number: 20140122110
    Abstract: Disclosed is a system and method to transform a complex diagnostic and management decision-making process found in western medicine into a novel and unique medical tool comprising a novel diagnostic decision support system and therapeutic optimization. The technologies result in more accurate diagnoses and more effective and appropriate therapeutic plans for individual patients.
    Type: Application
    Filed: October 30, 2013
    Publication date: May 1, 2014
    Applicant: Logical Images, Inc.
    Inventors: Arthur Papier, Noah Craft
  • Vaccination with killed but metabolically active (KBMA) protozoans with toll-like receptor agonists
    Patent number: 8709445
    Abstract: This invention provides compositions for inducing an immune response in a vertebrate host against a protozoan parasite. In certain embodiments the composition comprises a protozoan parasite comprising a psoralen-modified DNA, whereby said protozoan parasite is killed but metabolically active (KBMA); and optionally a Toll-like receptor agonist.
    Type: Grant
    Filed: July 31, 2008
    Date of Patent: April 29, 2014
    Assignee: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
    Inventors: Noah A. Craft, Kevin W. Bruhn, Ron A. Birnbaum
  • VACCINATION WITH KILLED BUT METABOLICALLY ACTIVE (KBMA) PROTOZOANS WITH TOLL-LIKE RECEPTOR AGONISTS
    Publication number: 20100310606
    Abstract: This invention provides compositions for inducing an immune response in a vertebrate host against a protozoan parasite. In certain embodiments the composition comprises a protozoan parasite comprising a psoralen-modified DNA, whereby said protozoan parasite is killed but metabolically active (KBMA); and optionally a Toll-like receptor agonist.
    Type: Application
    Filed: July 31, 2008
    Publication date: December 9, 2010
    Applicant: LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER
    Inventors: Noah A. Craft, Kevin W. Bruhn, Ron A. Birnbaum
  • VACCINE FORMULATIONS FOR LEISHMANIA
    Publication number: 20090028932
    Abstract: The present invention involves the use of Leishmania antigens and nucleic acids coding therefor as vaccines. It also provides a method of inducing protective immune responses in a subject through the use of specific delivery systems such as protein and/or DNA vaccines and Listeria monocytogenes vectors.
    Type: Application
    Filed: April 13, 2006
    Publication date: January 29, 2009
    Inventors: Mary E. Wilson, Daniella R.A. Martins, John E. Donelson, Selma M.B. Jeronimo, Kevin W. Bruhn, Noah A. Craft, Jeffery F. Miller